CSIMarket
 


Arrowhead Pharmaceuticals Inc   (ARWR)
Other Ticker:  
 
 

ARWR's EPS from Cont. Operations Growth by Quarter and Year

Arrowhead Pharmaceuticals Inc 's EPS from Cont. Operations results by quarter and year




ARWR EPS from Cont. Operations (in $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter September - -1.02 -0.81 -0.61
III Quarter June - -0.96 -0.68 -0.29
II Quarter March - 0.46 0.42 -0.26
I Quarter December -1.24 -0.39 -0.60 -0.20
FY   -1.24 -1.91 -1.67 -1.36



ARWR EPS from Cont. Operations first quarter 2024 Y/Y Growth Comment
Arrowhead Pharmaceuticals Inc in the first quarter 2024 recorded EPS loss from Cont. Operations of $ -1.24 .

According to the results reported in the first quarter 2024, Arrowhead Pharmaceuticals Inc achieved the best EPS from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Arrowhead Pharmaceuticals Inc ' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the first quarter 2024.




ARWR EPS from Cont. Operations ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter September - - - -
III Quarter June - - - -
II Quarter March - 9.52 % - -
I Quarter December - - - -
FY   - - - -

Financial Statements
Arrowhead Pharmaceuticals Inc 's first quarter 2024 EPS from Cont. Operations $ -1.24 ARWR's Income Statement
Arrowhead Pharmaceuticals Inc 's first quarter 2023 EPS from Cont. Operations $ -0.39 Quarterly ARWR's Income Statement
New: More ARWR's historic EPS from Cont. Operations Growth >>


ARWR EPS from Cont. Operations (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter September - - - -
III Quarter June - - - -
II Quarter March - - - -
I Quarter December - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Arrowhead Pharmaceuticals Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ARWR's I. Quarter Q/Q EPS from Cont. Operations Comment
I. Quarter 2024 results of -1.24 by Arrowhead Pharmaceuticals Inc appear even less good compare to the EPS loss from Cont. Operations -1.02 a quarter before.

Within Major Pharmaceutical Preparations industry Arrowhead Pharmaceuticals Inc achieved highest sequential EPS from Cont. Operations growth. While Arrowhead Pharmaceuticals Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ARWR's I. Quarter Q/Q EPS from Cont. Operations Comment
I. Quarter 2024 accomplishment of -1.24 by Arrowhead Pharmaceuticals Inc look even worse if you take a look at -1.02 in the fourth quarter.

Within Major Pharmaceutical Preparations industry Arrowhead Pharmaceuticals Inc achieved highest sequential EPS from Cont. Operations growth. While Arrowhead Pharmaceuticals Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


Arrowhead Pharmaceuticals Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative EPS from Cont. Operations 12 Months Ending $ -2.76 $ -1.91 $ -1.70 $ -1.42 $ -1.46
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment
Arrowhead Pharmaceuticals Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -3 in the Dec 31 2023 period.
The business is getting worse as the cumulative EPS loss from Cont. Operations is inflating from $ -1.91 in TTM ending quarter Sep 30 2023 and $ -1.6676828623243 for the twelve months ending in the quarter Dec 31 2022 Victor Hill mentioned.

Arrowhead Pharmaceuticals Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment
Arrowhead Pharmaceuticals Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -3 in the Dec 31 2023 period.
The results are worsening as the cumulative EPS loss from Cont. Operations is becoming larger from $ -1.91 in TTM ending quarter Sep 30 2023 and $ -1.6676828623243 for the twelve months ending in the quarter a year ago Victor Hill wrote.

Arrowhead Pharmaceuticals Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
ARWR's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for ARWR's Competitors
EPS from Cont. Operations Growth for Arrowhead Pharmaceuticals Inc 's Suppliers
EPS from Cont. Operations Growth for ARWR's Customers

You may also want to know
ARWR's Annual Growth Rates ARWR's Profitability Ratios ARWR's Asset Turnover Ratio ARWR's Dividend Growth
ARWR's Roe ARWR's Valuation Ratios ARWR's Financial Strength Ratios ARWR's Dividend Payout Ratio
ARWR's Roa ARWR's Inventory Turnover Ratio ARWR's Growth Rates ARWR's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Dec 31 2023
Nature s Sunshine Products inc 367.69%$ 367.687 
Inspire Medical Systems inc 359.55%$ 359.550 
National Healthcare Corp347.72%$ 347.720 
Boston Scientific Corporation288.89%$ 288.889 
Progyny Inc 283.22%$ 283.217 
Align Technology inc 204.08%$ 204.078 
Alcon inc 191.18%$ 191.176 
Tenet Healthcare Corp147.66%$ 147.658 
Davita Inc 120.38%$ 120.379 
Vericel Corporation117.03%$ 117.031 
Iqvia Holdings Inc 110.58%$ 110.579 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com